ASAS-PerSpA study finds Japanese patients with axial psoriatic arthritis have lower disease activity and better function than ...

Here six owners who've all been diagnosed with the same condition as their pet, tell their unusual stories - and how their ...

Living with ankylosing spondylitis (AS) brings its own set of challenges, especially when you think about starting a family. You might notice changes in your symptoms, energy levels, or even how your ...

These are more affordable versions of original biologic drugs that are frequently the best option to treat many chronic ...

PeptiDream is advancing the oral IL-17a/ IL-17F dual inhibitor peptide program into IND-enabling studies, while exploring ...

Pfizer Inc. announced positive results from a phase 3 investigational study evaluating the safety and efficacy of tofacitinib in adults with active ankylosing spondylitis (AS). Tofacitinib is not ...

According to DataM Intelligence, the global Disease-Modifying Therapies (DMTs) Market was valued at USD 65.32 billion in 2024 ...

As of Friday, December 26, Assertio Holdings, Inc.’s ASRT share price has surged by 1400.23%, which has investors questioning if this is right time to sell.

Professor Shakoor pointed out that rural women often cook by bending down and blowing on traditional stoves or sweep while ...

According to DataM Intelligence, the global Disease-Modifying Therapies (DMTs) Market was valued at USD 65.32 billion in 2024 and is projected ...

AbbVie to present data from multiple studies of Rinvoq, Humira & Skyrizi at the 2019 ACR/ARP) meeting: North Chicago, Illionis Tuesday, November 5, 2019, 16:00 Hrs [IST] AbbVie, a ...